VARMX
VarmX is a pharmaceutical spin-off from the Leiden University Medical Center. The mission of VarmX is to develop and manufacture therapeutic proteins to instantaneously restore blood clotting in bleeding patients. The lead product in the pipeline of VarmX is PseudoXa. PseudoXa is a modified recombinant human coagulation factor X which is capable of immediately restoring blood clotting in the presence of direct factor Xa anticoagulants (DOACS) such as rivaroxaban, apixaban, and edoxaban. These factor Xa coagulants are taken by millions of patients world-wide for the prevention and treatment of thrombosis and stroke, but as a side effect severe bleeding often occurs. PseudoXa is capable of stopping and preventing such bleedings thus making the usage of DOACS much safer.
VARMX
Industry:
Manufacturing Pharmaceutical Therapeutics
Founded:
2016-01-01
Address:
Leiden, Zuid-Holland, The Netherlands
Country:
The Netherlands
Website Url:
http://www.varmx.com
Total Employee:
1+
Status:
Active
Contact:
31 71 5156127
Email Addresses:
[email protected]
Total Funding:
63.3 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Google Tag Manager Apache Microsoft Exchange Online Office 365 Mail PHP
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Auris Medical
Auris Medical develops novel pharmaceutical therapies to prevent and treat severe inner ear disorders.
STipe Therapeutics
STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.
VetSource
VetSource is a pharmaceuticals company providing pet care medication and vaccination services.
Current Advisors List
Current Employees Featured
Founder
Investors List
European Innovation Council
European Innovation Council investment in Grant - VarmX
European Innovation Council
European Innovation Council investment in Venture Round - VarmX
BioGeneration Ventures
BioGeneration Ventures investment in Series B - VarmX
Lundbeckfonden Ventures
Lundbeckfonden Ventures investment in Series B - VarmX
Inkef
Inkef investment in Series B - VarmX
Ysios Capital
Ysios Capital investment in Series B - VarmX
InnovationQuarter
InnovationQuarter investment in Series B - VarmX
Life Sciences Partners
Life Sciences Partners investment in Series B - VarmX
Netherlands Enterprise Agency
Netherlands Enterprise Agency investment in Debt Financing - VarmX
BioGeneration Ventures
BioGeneration Ventures investment in Series A - VarmX
Official Site Inspections
http://www.varmx.com Semrush global rank: 6.05 M Semrush visits lastest month: 1.35 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
